Trial Profile
Long-term clinical outcomes and safety of Crizotinib in Relapsed Alk Positive Lymphoma Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Jul 2017
Price :
$35
*
At a glance
- Drugs Crizotinib (Primary)
- Indications Anaplastic large cell lymphoma
- Focus Adverse reactions; Therapeutic Use
- 20 Jul 2017 New trial record
- 25 Jun 2017 Results presented at the 22nd Congress of the European Haematology Association